Evaluation of blood oxidative stress‐related parameters in alcoholic liver disease and non‐alcoholic fatty liver disease

References

• Das S. K., Mukherjee S., Vasudevan D. M. Non‐alcoholic fatty liver diseases: an under recognized cause with emerging importance. Curr Sci 2006; 90: 659–65
   Web of Science ®Google Scholar
• Ludwig J., Viggiano T. R., McGill D. B., Ott B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434–8
   PubMed Web of Science ®Google Scholar
• Brunt E. M., Janney C. G., DiBisceglie A. M., Neuschwander‐Tetri B. A., Bacon B. R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467–74
   PubMed Web of Science ®Google Scholar
• Matteoni C. A., Younossi Z. M., Gramlich J., Boparai N., Liu Y. C., Mc Cullough A. J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413–19
   PubMed Web of Science ®Google Scholar
• Dixon J. B., Bharthal P. S., O'Brien P. E. Non‐alcoholic fatty liver disease: prediction of non‐alcoholic steatohepatitis and liver fibrosis in severly obese. Gastroenterology 2001; 121: 91–100
   PubMed Web of Science ®Google Scholar
• Das S. K., Vasudevan D. M. Drugs and non alcoholic steatohepatitis. Indian J Pharmacol 2006; 38: 238–42
   Google Scholar
• Sheth S. G., Gordon F. D., Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137–45
   PubMed Web of Science ®Google Scholar
• Day C. P., James O. F. Steatohepatitis – a tale of two hits. Gastroenterology 1998; 114: 842–5
   PubMed Web of Science ®Google Scholar
• Angulo P. Non‐alcoholic fatty liver disease. N Engl J Med 2002; 346: 1221–31
   PubMed Web of Science ®Google Scholar
• Diehl A. M. Nonalcoholic steatohepatitis. Semin Liver Dis 1999; 19: 221–9
   PubMed Web of Science ®Google Scholar
• Sies H. Biochemistry of oxidative stress. Angew Chem Int Ed Engl 1986; 25: 1058–71
   Web of Science ®Google Scholar
• Videla L. A., Fernandez V., Carrion Y., Azzalis L. A., Bainy A. C. D., Junqueira V. B. C. Biochemical mechanisms in hepatotoxicity: oxidative stress induced by xenobiotics and hormonal changes. J Braz Ass Adv Sci 1995; 47: 383–4
   Google Scholar
• Kaplowitz N. Mechanisms of liver cell injury. J Hepatol 2000; 32: 39–47
   PubMed Web of Science ®Google Scholar
• Videla L. A., Rodrigo R., Orellana M., Fernandez V., Tapia G., Quinones L., et al. Oxidative stress‐related parameters in the liver of non‐alcoholic fatty liver disease patients. Clin Sci 2004; 106: 261–8
   PubMed Web of Science ®Google Scholar
• Das S. K., Vasudevan D. M. Monitoring oxidative stress in patients with non‐alcoholic and alcoholic liver diseases. Indian J Clin Biochem 2005; 20: 24–8
   PubMedGoogle Scholar
• Perlemuter G., Davit‐Spraul A., Cosson C., Conti M., Bigorgne A., Paradis V., et al. Increase in liver antioxidant enzyme activities in non‐alcoholic fatty liver disease. Liver Int 2005; 25: 946–53
   PubMed Web of Science ®Google Scholar
• Sinnhuber R. O., Yu T. C., Yu T. C. Characterization of the red pigment formed in the thiobarbituric acid determination of oxidative rancidity. Food Res 1958; 23: 626–30
   Google Scholar
• Beutler E., Duron O., Kelly B. M. Improved method for determination of blood glutathione. J Lab Clin Med 1963; 61: 882–8
   PubMed Web of Science ®Google Scholar
• Das S. K., Vasudevan D. M. Modulation of lecithin activity by vitamin‐B complex to treat on ethanol induced oxidative stress in liver. Indian J Exp Biol 2006; 44: 791–801
   PubMedGoogle Scholar
• Pinto R. E., Bartley W. The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates. Biochem J 1969; 112: 109–15
   PubMed Web of Science ®Google Scholar
• Habig W. H., Pabst M. J., Jakoby W. B. Glutathione S‐transferase, the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130–9
   PubMed Web of Science ®Google Scholar
• Paglia D. E., Valentine W. N. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxides. J Lab Clin Med 1967; 70: 158–9
   PubMed Web of Science ®Google Scholar
• McCord J. M., Fridovich I. Superoxide dismutase – an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049–55
   PubMed Web of Science ®Google Scholar
• Paoletti F., Aldinucci D., Mocali A., Caparrini A. A sensitive spectro photometric method for the determination of the superoxide dismutase activity in tissue extract. J Biochem 1986; 154: 536–41
   Google Scholar
• Wilfred de Alwis N. M., Day C. P. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 2007; 27: 44–54
   PubMed Web of Science ®Google Scholar
• Weston S. R., Leyden W., Murphy R., Bass N. M., Bell B. P., Manos M. M., et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005; 41: 372–9
   PubMed Web of Science ®Google Scholar
• Madan K., Batra Y., Gupta S. D., Chander B., Rajan K. D., Tewatia M. S., et al. Non‐alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. World J Gastroenterol 2006; 12: 3400–5
   PubMed Web of Science ®Google Scholar
• Day C. P., Bassendine M. F. Genetic predisposition to alcoholic liver disease. Gut 1992; 33: 1444–7
   PubMedGoogle Scholar
• Das S. K., Balakrishnan V., Vasudevan D. M. Alcohol: Its health and social impact in India. Nat Med J India 2006; 19: 94–9
   PubMed Web of Science ®Google Scholar
• Kojima H., Sakurai S., Uemura M., Takekawa T., Morimoto H., Tamagawa Y., et al. Difference and similarity between non‐alcoholic steatohepatitis and alcoholic liver disease. Alcoholism Clin Exp Res 2005; 29 Suppl 12: 259S–63S
   Google Scholar
• Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., et al. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117–23
   PubMed Web of Science ®Google Scholar
• Loguercio C., De Girolamo V., de Sio I., Tuccillo C., Ascione A., Baldi F., et al. Non‐alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 2001; 35: 568–74
   PubMed Web of Science ®Google Scholar
• Sanyal A. J., Campbell‐Sargent C., Mirshahi F., Rizzo W. B., Contos M. J., Sterling R. K., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183–92
   PubMed Web of Science ®Google Scholar
• Das S. K., Vasudevan D. M. Biochemical diagnosis of alcoholism. Indian J Clin Biochem 2005; 20: 35–42
   Google Scholar
• Myrhed M., Berglund L., Bottiger L. E. Alcohol consumption and hematology. Acta Med Scand 1977; 202: 11–15
   PubMedGoogle Scholar
• Kristensson‐Aas A., Wallerstedt S., Alling C., Cederblad G., Magnusson B. Haematological findings in chronic alcoholics after heavy drinking with special reference to haemolysis. Eur J Clin Invest 1986; 16: 178–83
   PubMed Web of Science ®Google Scholar
• Cohen J. A., Kaplan M. M. The SGOT/SGPT ratio – an indicator of alcoholic liver disease. Dig Dis Sci 1979; 24: 835–8
   PubMed Web of Science ®Google Scholar
• Kamimoto Y., Horiuchi S., Tanase S., Morino Y. Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology 1985; 5: 367–75
   PubMed Web of Science ®Google Scholar
• Nalpas B., Vassault A., Le Guillou A., Lesgourgues B., Ferry N., Lacour B., et al. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology 1984; 4: 893–6
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J. M. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501–14
   PubMed Web of Science ®Google Scholar
• Plaa G. L., Witschi H. Chemicals, drugs and lipid peroxidation. Annu Rev Pharmacol Toxicol 1976; 16: 125–41
   PubMed Web of Science ®Google Scholar
• Pessayre D., Berson A., Fromenty B., Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57–69
   PubMed Web of Science ®Google Scholar
• Videla L. A., Iturriaga H., Pino M. E., Bunout D., Valenzuela A., Ugarte G. Content of hepatic reduced glutathione in chronic alcoholic patients: influence of the length of the abstinence and liver necrosis. Clin Sci 1984; 66: 283–90
   Web of Science ®Google Scholar
• Farooqui M. Y. H., Ahmed A. E. Circadian periodicity of tissue glutathione and its relationship with lipid peroxidation in rats. Life Sci 1984; 34: 2413–8
   PubMed Web of Science ®Google Scholar
• Pfafferoot C., Meiselman H. J., Hochstein P. The effect of MDA on erythrocyte deformability. Blood 1982; 59: 12
   PubMedGoogle Scholar
• Zima T., Fialova L., Mestek O., Janebova M., Crkovska J., Malbohan I., et al. Oxidative stress, metabolism of ethanol and alcohol‐related diseases. J Biomed Sci 2001; 8: 59–70
   PubMed Web of Science ®Google Scholar
• Kono Y., Fridovich I. Superoxide radical inhibits catalase. J Biol Chem 1982; 257: 5751–4
   PubMed Web of Science ®Google Scholar
• Kubota S., Sato N., Matsumura T., Kamada T. Chemiluminescence and superoxide dismutase in the plasma in patients with alcoholic and non‐alcoholic liver injuries. Alcohol 1985; 2: 469–72
   PubMedGoogle Scholar
• Kikugawa K., Kosugi H., Asakura T. Effects of MDA, a product of lipid peroxidation on the function and stability of haemoglobin. Arch Biochem Biophysics 1984; 229: 7
   PubMedGoogle Scholar
• Yesilova Z., Yaman H., Oktenli C., Ozcan A., Uygun A., Cakir E., et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 850–5
   PubMed Web of Science ®Google Scholar
• Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 2006; 65: 278–90
   PubMed Web of Science ®Google Scholar
• Day C. P. Is necroinflammation a prerequisite for fibrogenesis?. Hepatogastroenterology 1996; 43: 104–20
   PubMedGoogle Scholar
• Lee K. S., Buck M., Houglum K., Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c‐myb expression. J Clin Invest 1995; 96: 2461–8
   PubMed Web of Science ®Google Scholar
• Hirayama C., Suzuki H., Takada A., Fujisawa K., Tanikawa K., Igarashi S. Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide. J Gastroenterol 1996; 31: 242–8
   PubMed Web of Science ®Google Scholar
• Lieber C. S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004; 34: 9–19
   PubMed Web of Science ®Google Scholar
• Greenwel P. Acetaldehyde‐mediated collagen regulation in hepatic stellate cells. Alcohol Clin Exp Res 1999; 23: 930–3
   PubMedGoogle Scholar
• Bonnefont‐Rousselot D., Ratziu V., Giral P., Charlotte F., Beucler I., Poynard T. Lido Study Group. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment Pharmacol Ther 2006; 23: 91–8
   PubMedGoogle Scholar